Aesku NY Overview

  • Founded
  • 2003

  • Status
  • Private

  • Employees
  • 15

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Aesku NY General Information


Developer of a screening technology intended for connective tissue disorders such as lupus. The company provides test methods for the detection of autoantibodies for connective tissue and other autoimmune disorders, enabling clinicians to detect patients with diseases and provide treatments accordingly.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Services
Primary Office
  • Buffalo, NY
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aesku NY Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 05-Jun-2014 Completed Generating Revenue
1. Spin-Off 01-Jan-2003 Completed Generating Revenue
To view Aesku NY’s complete valuation and funding history, request access »

Aesku NY Executive Team (1)

Name Title Board Seat Contact Info
Vijay Kumar Ph.D Vice President & Chief Operating Officer
To view Aesku NY’s complete executive team members history, request access »

Aesku NY Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aesku NY Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Start-up NY Accelerator/Incubator 000 0000 000000 0
To view Aesku NY’s complete investors history, request access »